Several regions of chromsome arm 8p are frequently deleted in a variety of human malignancies including those of the prostate, head and neck, lung, and colon, suggesting that there is more than one tumor suppressor gene on this chromosome arm. Both laryngeal and oral squamous cell carcinomas exhibit three distinct and nonoverlapping regions of deletion on 8p. We have further re®ned the localization of the putative suppressor in 8p23 by using eight microsatellite loci to create a high resolution deletion map of 150 squamous cell carcinomas of the larynx and oral cavity. These new data demonstrate that there are two distinct classes of deletion within this relatively small region of the chromosome and suggest two possible locations for the gene within the D8S264 to D8S1788 interval. We also determined that there is little dierence between the allelic loss frequencies of microsatellites mapping near the telomeric ends of other chromosome arms and loci mapping to more centromere proximal regions of the same arm. These data suggest that the high allelic loss frequencies seen at 8p23 loci are not the result of a generalized instability of chromosome ends and are instead consistent with the activation of a speci®c suppressor gene.
Introduction
A growing body of evidence suggests that there are several tumor suppressor genes on the short arm of chromosome 8 (8p) and that these genes are inactivated in a variety of human malignancies (Fujiwara et al., 1993; Macgrogan et al., 1994; Yaremko et al., 1994) . These putative suppressors, however, have yet to be cloned. A study of laryngeal squamous cell carcinomas reported by our group presented evidence for the involvement of a novel suppressor gene mapping to the sub-telomeric region of 8p (Sunwood et al., 1996) . These ®ndings are consistent with loss of heterozygosity studies of both oral cavity squamous cell carcinoma (Wu et al., 1997) and prostatic adenocarcinoma (Macoska et al., 1995) . In addition, our clinical correlation study of a population of supraglottic squamous cell carcinoma patients suggests that allelic loss at the D8S264 locus in 8p23 is signi®cantly associated with early tumor recurrence and shorter disease-speci®c survival. Inactivation of this tumor suppressor may confer a more aggressive tumor phenotype and may serve as an independent predictor of prognosis.
The high resolution deletion mapping study of 150 head and neck squamous cell carcinomas reported here examined allelic losses at eight polymorphic loci in the 8p23 region in order to further localize the putative suppressor. Loss of 8p sub-telomeric DNA was found to be a frequent event in these tumors. Deletion breakpoints from tumors with partial deletions of 8p23 suggest two potential locations for the suppressor gene within 8p23.
Results

Deletion mapping of 8p23
We examined eight polymorphic markers in 8p23 for loss of heterozygosity in 150 squamous cell carcinomas of the head and neck. On average, patients were heterozygous for ®ve of the seven loci examined in all tumors, with no patient being homozygous at all loci. Of the 150 tumors investigated, 77 (51%) exhibited allelic loss at one or more of the loci from D8S504 to D8S262. Most of the tumors with 8p23 allelic loss lost heterozygosity for all the loci examined and were not useful for deletion mapping. Ten tumors exhibited partial deletions of this region useful for deletion mapping (Table 1) . Allelic losses detected in these tumors had a clear quantitative dierence from loci retaining heterozygosity.
The data in Table 1 demonstrate that there are two classes of deletions aecting microsatellites in 8p23. Three tumors appear to have terminal deletions, all of which result in allelic loss at D8S504 and D8S264. The deletion in tumor 99 appears to end between D8S264 and D8S1806 while that of tumor F39 extends more proximally to the interval between D8S1781 and D8S1788 (Table 1, Figure 1 ). The proximal endpoint of the deletion in tumor 81 cannot be as precisely determined because of homozygosity at D8S1806.
A second group of three tumors appears to have internal deletions extending towards but not deleting D8S504 (Table 1 ). The breakpoint in tumor F44 lies within the D8S1806 to D8S1824 interval (Table 1, Figure 1 ). The deletions in the other two tumors extend further towards the telomere, ending between D8S504 and D8S264 (Table 1) .
The pattern of allelic loss in the remaining four tumors is complex as they appear to have both terminal and internal deletions (e.g. tumors F2, and 171, Table  1 ). The apparent retention of heterozygosity at loci within an otherwise deleted region is frequently taken as indicative of the masking of homozygous deletions by small amounts of contaminating normal tissue DNA (Cairns et al., 1994) . We assayed for homozygous deletions using the multiplex PCR technique described by Cairns et al. (1994) . None of the loci tested exhibited the 90% reduction in signal expected of homozygous deletions as de®ned by Cairns et al. (1994) suggesting that this pattern is indeed the result of the presence of two distinct nonoverlapping 8p23 deletions in these tumors. Demonstration of the exact nature of these potentially complex rearrangements will require further analysis by¯uorescent in situ hybridization.
Frequency of allelic loss in subtelomeric regions
High frequencies of allelic loss within a given chromosomal region are generally regarded as indicative of a nearby tumor suppressor gene. However, the placement of the 8p23 minimally deleted region so close to the end of the chromosome raises the question of whether these deletions are actually the result of the loss of chromosomal sequences following telomere erosion. Such a phenomenon would be expected to act on all chromosomes, therefore, many deletions created by this mechanism would not result in suppressor inactivation. We reasoned that if this mechanism of deletion was active in squamous cell carcinomas, then microsatellites mapping near the telomeres of many chromosome arms should have high frequencies of allelic loss and that those frequencies should be higher than those of more centromeric loci. To test this hypothesis, we determined the frequencies of allelic loss at microsatellites mapping at or near the telomeres of ten chromosome arms in a subset of the tumors used for the deletion mapping study ( Table 2 ). The microsatellites selected were as close as possible to the telomeric end of their respective chromosome's linkage map at the time of their selection. Six of those arms (5p, 6p, 7p, 8q, 10p and 12p) had previously been shown to have low frequencies of allelic loss in our The microsatellite loci are listed in their telomere to centromere map order as described in Materials and methods. *=allelic loss; *=no allelic loss; H=homozygote, nd=no data Figure 1 Selected examples of allelic loss de®ning the smallest region of deletion in the sub-telomeric region of chromosome arm 8p. Phosphor screen imager generated traces of electrophoretically fractionated PCR products from normal tissue (solid line) and matching tumor (dashed line). The peak height of the retained allele of the tumor has been normalized to the peak height of its normal tissue counterpart. The position of the lost allele is indicated by an arrow allelotype of laryngeal squamous cell carcinomas (Scholnick et al., 1998) . Microsatellites on the other four arms (3p, 8p, 9q and 13q) had higher than average frequencies of allelic loss in that study. The distal band of 13q, 13q34, is also thought to contain a tumor suppressor gene inactivated in head and neck cancers (Maestro et al., 1993; Yoo et al., 1994; Gupta et al., submitted) . The data in Table 2 demonstrate that there were no statistically signi®cant dierences in allelic loss frequencies between loci near the telomere and those located more proximally on any of the chromosome arms tested. Signi®cantly, ®ve of the six chromosome arms previously found to have low frequencies of allelic loss (5p, 7p, 8q, 10p and 12p) also have low allelic loss frequencies at the loci nearer to the telomere. These data suggest that frequent allelic loss at microsatellites near the ends of chromosomes is not a generalized phenomenon in these tumors.
Discussion
Allelic losses at 8p23 microsatellite loci are a common event in squamous cell carcinomas of the larynx and oral cavity Wu et al., 1997) and the combined mapping data from these prior studies suggests that a tumor suppressor gene is located in the interval between D8S264 and D8S262. Deletions of 8p23 have also been reported in prostatic adenocarcinomas (Leach et al., 1996; Macoska et al., 1995; Washburn et al., 1997) . Additional mapping studies will be required to determine whether the same suppressor gene is involved in both types of cancer.
In this study, we have used additional tumor samples and microsatellite loci to further restrict the localization of this putative squamous cell carcinoma suppressor. Although most of the tumors with 8p23 allelic loss appear to have lost a large portion of the distal end of the chromosome arm, the two classes of smaller deletions aided in the localization of the suppressor. Our deletion data can be interpreted in several ways. At one extreme, the two classes of deletions we have detected can be viewed as acting on two dierent genes with the 8p23 suppressor gene being located between the 8p telomere and D8S1806. In this model, the internal deletions would aect only the next more proximal suppressor (our region II in 8p22-p21 , the central region of Wu et al. (1997) , in which case the location of their breakpoints in our region of interest is only fortuitous. This model, however, is unlikely to be correct because Wu et al. (1997) have reported on two oral cavity squamous cell carcinomas with allelic losses at D8S262 but not at D8S264 or D8S518. The deletions in these two tumors cannot be inactivating the 8p22-p21 suppressor, and if they have any phenotypic eects at all they must come through inactivation of the 8p23 suppressor. If both studies are indeed detecting the inactivation of the same suppressor gene, the data of Wu et al. (1997) suggest that it must map between D8S264 and D8S518. Combining their deletion data with ours further restricts that region to the interval between D8S264 and D8S1788 (based on the centromere proximal breakpoint of tumor F39, Table 1 ).
Further examination of our data suggests two possible locations for the suppressor within the D8S264 and D8S1788 interval. The overlap of the deletions in tumors F39 and F44 suggests the existence of a minimal region of deletion between D8S1806 and D8S1788 (Table 1 ). These two loci are contained within three overlapping BAC clones with inserts of 155, 120 and 171 kb in length (PC Sun et al., manuscript in preparation). The sum of the sizes of these three BAC clones sets an upper limit on the physical size of this genetic interval. This interpretation is consistent with the conclusions of Wu et al. (1997) . Alternatively, the overlap between the terminal deletion in tumor 99 and the internal deletions in tumors 79 and 224 (Table 1) suggests a minimal region between D8S504 and D8S1806. The ®ndings of Wu et al. (1997) further restrict this minimal region to the D8S264 to D8S1806 interval. Our current data do not allow us to distinguish between these two possibilities. Clearly, the mapping of deletion breakpoints in additional tumors will be required to resolve this issue.
If the suppressor gene is ultimately shown to map to the D8S1806 and D8S1788 interval, it will be necessary to determine whether or not shorter terminal deletions such as seen in tumor 99 have any eect on its function. While it is formally possible that these deletions are random and have no phenotypic eect on the cancer cell, it is also possible that these deletions could reduce the expression of the suppressor by indirect means. By analogy with the yeast, Sacchar- omyces cerevisiae, terminal deletions could result in the repression of genes near the breakpoint by a heterochromatin-driven telomere position eect (reviewed in Gotta and Gasser, 1996) . If true, this could complicate the search for the suppressor gene by causing inactivation without mutation.
We have strong evidence for the frequent deletion of a portion of 8p23 but, as of yet, lack a biological demonstration of the ability of wildtype sequences from this region to suppress cancer cells. There is in vivo evidence that microcell mediated transfer of a wildtype chromosome 8 suppresses the growth or tumorigenicity of colorectal and breast cancer cells (Gustafson et al., 1996; Spanknebel et al., 1997; Tanaka et al., 1996) , but no one has reported speci®cally studying the suppressing eects of transferring only 8p23 DNA. This makes it formally possible that the deletions we observe do not result in suppressor inactivation. In light of this, we tested one of the alternative hypotheses: that the frequent allelic loss observed at 8p23 loci is the result of a generalized instability of distal chromosomal sequences in cancer cells. Such instability should manifest itself as frequent allelic loss for distal microsatellites on many chromosome arms, including those arms otherwise thought to lose heterozygosity infrequently. Our examination of markers on ten chromosome arms suggests that such instability is not commonplace, ruling out the possibility that the high frequency of 8p23 allelic loss is the result of a generalized process aecting the ends of all chromosome arms.
The ®nding that allelic loss at one locus within 8p23 (D8S264) is signi®cantly associated with poor diseasespeci®c survival and early tumor recurrence in a population of patients with supraglottic laryngeal cancer is further evidence for the involvement of an 8p23 suppressor gene in these tumors. If the inactivation of an 8p23 tumor suppressor does indeed result in more aggressive tumor behavior, its identi®cation will not only provide insight into the mechanisms of tumorigenesis but could also aid in the prediction of clinical outcome and response to therapy.
Materials and methods
Tumor specimens
DNA samples from 150 tumors were analysed. Formalin®xed and paran-embedded specimens from 107 cases of primary supraglottic cancer and matched normal tissue were obtained from the archives of the Department of Pathology at the Washington University School of Medicine. In addition, fresh tissue samples from 23 laryngeal and 20 oral cavity primary tumors, resected by the faculty of the Department of Otolaryngology ± Head and Neck Surgery, were procured at the time of surgery and snap frozen. The collection of these specimens has been approved by the Washington University Medical Center Human Studies committee. Patient matched blood samples were used as a source of normal DNA for analysis of these specimens. The histology of all tumor specimens was reviewed by a head and neck pathologist (S El-Mofty) and con®rmed to be squamous cell carcinoma. Patients with synchronous second primary tumors were excluded from this study, as were those who had received preoperative radiotherapy.
DNA extraction
Microtome sectioning (15 mm thick) of the paran embedded archival specimens and collection of tumor tissue by microdissection were performed as previously described (Scholnick et al., 1994) . Snap-frozen specimens were cut into 16 ± 20 mm sections on a cryostat, stained with hemotoxylin and eosin, and microdissected under a layer of glycerol containing 1 mM EDTA. The glycerol decreases refraction, thus improving visualization of the tissue by microscopy. Areas of the section containing more than 30% normal cells were removed from the slide with a #11 scalpel blade. The normal tissue suspended in the glycerol was then washed away with 100% ethanol and the remaining tumor tissue collected by scraping the slide.
Extraction and quanti®cation of DNA were performed as previously described (Scholnick et al., 1994) .
Analysis of microsatellite repeat polymorphisms
Eight microsatellite simple sequence repeat polymorphisms mapping to 8p23 were examined (D8S504, D8S264, D8S1806, D8S1824, D8S1781, D8S1788, D8S262, and D8S518). D8S518 was only examined in a subset of cases thought to have partial deletions of 8p23. The map order of the microsatellite loci was determined by combining data from several sources. The yeast arti®cial chromosome (YAC) contig described by Ranta et al. (1996) yields the order: telomere, D8S504, D8S264. This contig places D8S1806, D8S1824, D8S1781, D8S1788, and D8S262 on the centromeric side of D8S264 without resolving their order. We used content mapping of a bacterial arti®cial chromosome (BAC) contig to arrive at the order: D8S1806, D8S1824, D8S1781, D8S1788, D8S262 (PC Sun et al., manuscript in preparation). The orientation of our BAC contig relative to the chromosome arm is based on the publicly available linkage maps (Genome Database, http://gdbwww.gdb.org). These linkage maps place D8S518 centromeric to D8S262 (Genome Database, http://gdbwww.gdb.org). Taken together the most likely map order is: telomere, D8S504, D8S264, D8S1806, D8S1824, D8S1781, D8S1788, D8S262, D8S518, centromere.
Oligonucleotide primers for PCR ampli®cation were obtained either from Research Genetics (Huntsville, AL, USA) or the oligonucleotide synthesizing facility of the Washington University School of Medicine Department of Surgery. We used the Genbank entries for three of the polymorphic loci to develop new primers pairs that ampli®ed more robustly with our genomic DNAs. Primer sequences were selected using the Amplify software package (v1.2, Dr William Engels, University of Wisconsin). The primers sequences are (all written 5' to 3'): D8S504A, GGGAACTGTTGCACTTTCCA; D8S504B; TTCCAGAT-GGGAAAACCAAG; D8S1824A, GGAAATATGTCCC-CCTGTGC; D8S1824B, TCACAAAAGATTGGAGGCCC; D8S1781A, GGAGAAACCTCACAGCATTG; and D8S178-1B, ATTTAAGCTTCCCATGGGTC. One primer from each pair was isotopically end-labeled and used in 5 ml polymerase chain reactions (PCR) containing 5 ng of genomic DNA as previously described (Scholnick et al., 1994) . The amplifications were performed in Perkin-Elmer 480 (Perkin-Elmer/ Cetus, Norwalk, CT, USA) or Hybaid Omnigene (Woodbridge, NJ, USA) thermal cyclers for 35 cycles at an annealing temperature determined to be optimal for each polymorphism. Normal and corresponding tumor tissue DNA were ampli®ed in parallel. Selected specimens were re-examined using duplicate reactions containing 20 ng of genomic DNA in a ®nal volume of 20 ml. These conditions result in a more reproducible ratio between the signals from the large and small alleles of samples that do not amplify well.
PCR products were fractionated electrophoretically on 6% polyacrylamide denaturing gels, and the majority of reactions were visualized with a Storm 820 phosphor screen imager (Molecular Dynamics, Sunnyvale, CA, USA). In some experiments, the gels were visualized by autoradiography using Kodak X-Omat ®lm (Kodak, Rochester, NY, USA).
Multiplex PCR was performed by using either our standard conditions as described above or using the PCR buers and conditions described by Cairns et al. (1994) . D8S549, which maps proximally in 8p23, was used as the control locus for comparing the signals generated from loci being tested for homozygous deletions.
De®nition of allelic loss
Images acquired by phosphor screen imager were analysed using the area integration method provided by the ImageQuant software package (versions 1.11 and 1.2 for Macintosh, Molecular Dynamics, Sunnyvale, CA, USA). Autoradiographic data were analysed using NIH Image software (developed at the US National Institutes of Health and available at http://rsb.info.nih.gov/nih-image/).
Allelic loss was de®ned as a greater than 50% reduction in the signal intensity of one allele from the tumor tissue when compared to the corresponding allele from the matched normal tissue. Quantitative data were analysed in Microsoft Excel (version 5.0a for Macintosh, Microsoft Corp., Redmond, WA, USA) using the expression (L t /S t )/(L n /S n ) where S t and S n are the signals from the small allele of the tumor and normal tissue, respectively; and L t and L n are the signals from the large allele of the tumor and normal tissue, respectively. This formula yields a value of less than 0.5 or greater than two when allelic loss has occurred and it corrects for instances where normal and tumor DNAs do not amplify equally. In tumors where the alleles dier in size by only two or four base pairs, a stutter band from the large allele may comigrate with the full length product ampli®ed from the smaller allele. We extracted the contribution made by the small allele from this composite signal by using the average ratio in signal intensity between the allelic band and the appropriate stutter band as measured in several cases with more widely separated alleles. These ratios are highly reproducible for a given microsatellite.
